Ocugen (NASDAQ: OCGN) reported Q2 EPS of ($0.07), $0.02 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.48 million versus the consensus estimate of $833.29 thousand.

For earnings history and earnings-related data on Ocugen (OCGN) click here.